Insmed Inc (INSM): Next-Year EPS Estimate 160.09%
As of 2026-08-25, Insmed Inc (INSM) has a next-year EPS growth estimate of 160.09%. Featured in our EPS revision report on 2026-08-07.
On 2026-08-25, analyst consensus for INSM's next-year EPS growth shifted from 156.28% to 160.09% — a positive change of 3.81 percentage points. Current-year growth is projected at 75.09%.
What's Driving This
The primary driver is the upward revision to next-year EPS growth estimates, which have risen by 2.20 percentage points since the initial downgrade. This revision is plausibly tied to Insmed's Q2 earnings call, where BRINSUPRI surged 49% sequentially, prompting the company to raise revenue guidance and expand its peak sales outlook. Estimate momentum has continued, with three upward revisions against two downward moves, supporting the stock's sustained climb.
Generated 2026-08-25 from news as of 2026-08-25
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 160.09%
- EPS growth this year
- 75.09%
- EPS next quarter (est)
- -$0.39
- Last price
- $123.89
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-25 | 160.09% | 75.09% | -$0.39 | $123.89 |
| 2026-08-24 | 156.28% | 75.09% | -$0.39 | $123.98 |
| 2026-08-23 | 156.28% | 75.09% | -$0.39 | $125.77 |
| 2026-08-21 | 156.28% | 75.09% | -$0.39 | $125.77 |
| 2026-08-20 | 156.28% | 75.09% | -$0.39 | $125.08 |
| 2026-08-19 | 156.28% | 75.09% | -$0.39 | $130.66 |
| 2026-08-18 | 156.28% | 75.09% | -$0.39 | $128.46 |
| 2026-08-17 | 156.28% | 75.09% | -$0.39 | $128.32 |
| 2026-08-16 | 156.28% | 75.09% | -$0.39 | $123.74 |
| 2026-08-14 | 156.28% | 75.09% | -$0.39 | $123.74 |
| 2026-08-13 | 156.28% | 75.09% | -$0.39 | $126.33 |
| 2026-08-12 | 162.75% | 75.24% | -$0.38 | $132.28 |
| 2026-08-11 | 161.13% | 74.72% | -$0.38 | $132.57 |
| 2026-08-10 | 163.17% | 74.72% | -$0.38 | $134.75 |
| 2026-08-09 | 157.89% | 73.64% | -$0.40 | $131.10 |
| 2026-08-07 | 159.87% | 73.47% | -$0.39 | $131.10 |
| 2026-08-06 | 115.63% | 60.82% | -$0.58 | $132.55 |
| 2026-08-05 | 112.75% | 59.34% | -$0.69 | $99.02 |
| 2026-08-04 | 112.75% | 59.34% | -$0.69 | $98.75 |
| 2026-08-03 | 112.75% | 59.34% | -$0.69 | $98.45 |
| 2026-08-02 | 113.05% | 59.35% | -$0.69 | $98.60 |
| 2026-07-31 | 113.05% | 59.35% | -$0.69 | $98.60 |
| 2026-07-30 | 112.80% | 59.19% | -$0.70 | $101.49 |
| 2026-07-29 | 112.80% | 59.19% | -$0.70 | $103.12 |
| 2026-07-28 | 112.80% | 59.19% | -$0.70 | $104.13 |
| 2026-07-27 | 112.80% | 59.19% | -$0.70 | $104.73 |
| 2026-07-26 | 112.80% | 59.19% | -$0.70 | $106.92 |
| 2026-07-24 | 112.80% | 59.19% | -$0.70 | $106.92 |
| 2026-07-23 | 112.80% | 59.19% | -$0.70 | $107.41 |
| 2026-07-22 | 112.80% | 59.19% | -$0.70 | $106.64 |
Reports Featuring INSM
Recent News
- Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...GuruFocus.com
- Insmed Inc (INSM) (Q2 2026) Earnings Call Highlights: BRINSUPRI Surges 49% Sequentially, ...GuruFocus.com
- Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales OutlookInvestorsHub
- Insmed Raises BRINSUPRI Revenue Guidance After Strong Q2 Growth and Expands Peak Sales OutlookInvestorsHub
- Insmed: Q2 Earnings SnapshotAssociated Press
- Insmed: Q2 Earnings SnapshotAssociated Press
- Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePR Newswire
- Insmed Reports Second-Quarter 2026 Financial Results and Provides Business UpdatePR Newswire
- Insmed Appoints Samuele Butera as Senior Vice President, General Manager, Global RespiratoryPR Newswire
- Nasdaq-100 Adds New AI and Space Winners. These Stocks Are SoaringGuruFocus.com
Screen Performance
Aggregate stats across all 2014 tickers our top-EPS-revision screen has flagged over the past 146 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +19.9%
- Large revisions captured
- 1606
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Insmed Inc's next-year EPS growth estimate?▾
As of 2026-08-25, Insmed Inc (INSM) has a next-year EPS growth estimate of 160.09%, based on analyst consensus.
When was the latest EPS estimate revision for INSM?▾
The most recent revision occurred on 2026-08-25, when analysts adjusted the next-year EPS growth estimate from 156.28% to 160.09%.
What sector and industry does Insmed Inc belong to?▾
Insmed Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. INSM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Insmed Inc (INSM) appears here because it was detected by our daily top-EPS-revision-performer screen.